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Treating fever 
signifi cantly 
increases 
comfort, activity, 
feeding, and 
fl uid intake, but 
doesn’t reduce 
recurrence of 
febrile seizures.
  Does lowering a fever >101°F 
in children improve clinical 
outcomes? 
 it depends on which outcomes
 you look at. Treating fever sig-
nifi cantly increases comfort, activity, feed-
ing, and fl uid intake and decreases the 
patient’s temperature compared with pla-
cebo (strength of recommendation (SOR): 
A, multiple randomized controlled tri-
als [RCTs]). It doesn’t shorten or prolong 
the overall duration of illness or reduce 
the recurrence of febrile seizures (SOR: A, 
multiple RCTs). In patients with varicella, 
reducing fever prolongs the time it takes for 
lesions to crust, but doesn’t appear to cause 
group A streptococcal necrotizing fasciitis 
(SOR: B, multiple prospective cohorts).
Ibuprofen and acetaminophen reduce 
fever eff ectively and safely; their side eff ect 
levels are similar to placebo (SOR: A, mul-
tiple RCTs). Physical methods of cooling 
also are eff ective for lowering fever (SOR: A, 
high-quality meta-analysis).
Evidence summary
Th e possible risks and benefi ts of lowering 
fever with antipyretics have prompted much 
discussion in the medical literature. Most 
evidence supporting the useful eff ects of fe-
ver comes from animal models. A few human 
studies in special populations (patients with 
brain trauma) suggest that antipyretics may 
worsen certain aspects of disease processes.1
However, many studies show that antipyretics 
do clinically benefi t, and don’t harm, the typi-
cal child with an upper respiratory illness.2-4
Acetaminophen improves some 
symptoms, but doesn’t shorten fever
A double-blind, randomized, placebo-
controlled trial of 210 children with upper 
respiratory illness showed that giving acet-
aminophen signifi cantly increased short-
term temperature reduction compared with 
placebo (0.36°F vs 0.09°F/hr; P<.001). Acet-
aminophen also improved subjective symp-
toms at 6 hours over placebo: activity (60% vs 
16%;  P<.001), alertness (58% vs 21%; P<.001), 
comfort (37% vs 7%; P<.001), mood (36% vs 
12%; P<.001), appetite (20% vs 1%; P<0.001), 
and fl uid intake (22% vs 2%; P<.001).2 Total 
time until complete resolution of fever (de-
fi ned as no fever with or without medication) 
didn’t diff er between treatment and placebo 
groups (32 hr for acetaminophen vs 36 hr for 
placebo; P=.23).2
A similar study failed to show a statisti-
cally signifi cant diff erence between acet-
aminophen and placebo in fever clearance 
time (34.7 vs 36.1 hr), mood, comfort, or ap-
petite. However, the study did fi nd signifi cant 
improvement in activity (38% vs 11%; P=.005) 
and alertness (33% vs 12%; P=.036) based on 
parents’ reports.3 
Ibuprofen is a better antipyretic 
than acetaminophen
A meta-analysis (N=84,192) comparing ac-
etaminophen with ibuprofen found both 
drugs to be equally effi  cacious analgesics; 
ibuprofen was a more eff ective antipyretic. 
Both drugs had the same level of adverse out-
comes when compared with each other and 
placebo.5  
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An RCT involving 
children with 
varicella  
found that 
acetaminophen 
increased 
the time for 
lesions to crust 
compared with 
placebo. 
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Lowering fever doesn’t reduce 
recurrence of febrile seizures
Antipyretics don’t appear to aff ect the recur-
rence of febrile seizures. In a well-designed, 
randomized, double-blind, placebo-controlled 
trial, 230 patients 1 to 4 years of age with 1 or 
more risk factors for febrile seizures were ran-
domized to fever reduction with ibuprofen or 
placebo. Th e estimated 2-year probability for 
recurrent febrile seizure was 32% in the ibupro-
fen group and 39% for the placebo group. Th e 
diff erence between the groups was not signifi -
cant (relative risk=0.9; 95% confi dence interval 
[CI], 0.6-1.5).6  
Varicella lesions crust more slowly 
with acetaminophen
An RCT involving 68 children with varicella 
found that acetaminophen increased the time 
for lesions to crust compared with placebo 
(6.7 days for acetaminophen vs 5.6 days for place-
bo) and that acetaminophen didn’t alleviate itch-
ing or improve appetite. However, patients taking 
acetaminophen were more active by day 2.7 
NSAIDs don’t cause necrotizing fasciitis
A case-control study of 48 children with vari-
cella suggested an association between ibu-
profen and increased incidence of necrotizing 
soft tissue infections (odds ratio [OR]=11.5; 
95% CI, 1.4-96.9),8 but larger reviews haven’t 
borne out this fi nding. A review of 5 prospec-
tive studies of nonsteroidal anti-infl amma-
tory drugs and invasive soft-tissue infections 
(N=912; 114 cases of necrotizing fasciitis) 
failed to show any connection. Th e largest 
study (474 cases) suggested a trend that was 
not statistically signifi cant (OR=3.5; 95% CI, 
0.8-16).9 
Nonpharmacologic measures 
also lower fever
A Cochrane review showed that cool water 
sponging caused fever reduction similar to an-
tipyretics at 1 hour; sponging combined with 
ibuprofen reduced the proportion of patients still 
febrile at 1 hour. Common side eff ects of spong-
ing included goose pimples and shivering. Th e 
antipyretic eff ect didn’t last beyond a few hours.10
Recommendations
Concerning treatment of fever, Nelson’s 
Pediatrics states, “Fever with temperatures 
less than 39°C (102.2°F) in healthy children 
generally does not require treatment. As tem-
peratures become higher, patients tend to 
become more uncomfortable and adminis-
tration of antipyretics often makes patients 
feel better. Other than providing symptom-
atic relief, antipyretic therapy does not change 
the course of infectious diseases. Antipyretic 
therapy is benefi cial in high-risk patients who 
have chronic cardiopulmonary diseases, met-
abolic disorders, or neurologic diseases and in 
those who are at risk for febrile seizures. Hy-
perpyrexia (>41°C [105.8°F]) indicates greater 
risk for severe infection and should always be 
treated with antipyretics.”11                          JFP
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